REN and obesity due to melanocortin 4 receptor deficiency: This systematic review demonstrates that direct renin inhibition with aliskiren provides BP-lowering efficacy comparable to ACEi and ARBs, with potential additional benefits in select subgroups such as patients with obesity-related hypertension and those with advanced microalbuminuria.